Related Experiment Video

Updated: Jul 18, 2026

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases
03:22

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases

Published on: March 1, 2024

Long-term antibiotic treatment with roxithromycin in patients with multiple sclerosis

R Woessner1, M T Grauer, A Frese

  • 1Dept. of Neurology, Westpfalz Medical Center, 67655, Kaiserslautern, Germany.

Infection
|December 21, 2006
PubMed
Abstract

Insights

Antibiotic treatment with roxithromycin did not benefit patients with multiple sclerosis (MS). This study suggests that Chlamydia pneumoniae infection is unlikely to cause MS, as roxithromycin offered no improvement over placebo.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Microbiology

Background:

  • Conflicting evidence exists regarding the association between Chlamydia pneumoniae infection and multiple sclerosis (MS).
  • Investigating potential therapeutic strategies for MS is crucial due to its debilitating nature.

Purpose of the Study:

  • To evaluate the efficacy of antibiotic therapy in patients diagnosed with multiple sclerosis.
  • To determine if Chlamydia pneumoniae plays a causative role in the development of MS.

Main Methods:

  • A randomized, placebo-controlled, double-blind study was conducted.
  • 28 patients with confirmed MS received 12 months of oral roxithromycin or placebo in three cycles.
  • Outcomes measured included the Expanded Disability Status Scale (EDSS) and relapse rates.

Main Results:

  • No significant differences in EDSS or relapse rates were observed between the roxithromycin and placebo groups in relapsing-remitting MS patients.
  • The antibiotic treatment did not demonstrate any therapeutic benefit compared to placebo.

Conclusions:

  • Long-term antibiotic treatment with roxithromycin does not benefit patients with multiple sclerosis.
  • The findings suggest that a causative link between Chlamydia pneumoniae infection and MS is improbable.

Related Concept Videos

Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...